Ox-LDL-induced TGF-β1 production in human alveolar epithelial cells: involvement of the Ras/ERK/PLTP pathway

J Cell Physiol. 2012 Sep;227(9):3185-91. doi: 10.1002/jcp.24005.

Abstract

Oxidized-low density lipoprotein (Ox-LDL) has been shown to play an important role in impaired surfactant metabolism and transforming growth factor-β1 (TGF-β1) is a critical mediator in the pathogenesis of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). In this study, we investigated whether Ox-LDL can induce TGF-β1 protein production, and if so, how it achieves this induction in human alveolar epithelial cells (A549). We show here that Ox-LDL not only caused a dose- and time-dependent up-regulation of TGF-β1 production, but also increased Smad3 phosphorylation, Ras/extracellular signal-regulated kinase (ERK) activity and phospholipid transfer protein (PLTP) expression in A549 cells. The inhibition of Ras/ERK activity with specific inhibitors significantly suppressed Ox-LDL-induced TGF-β1 production, Smad3 phosphorylation and PLTP expression. Furthermore, treatment of cells with PLTP siRNA suppressed both TGF-β1 release and Smad3 activation induced by Ox-LDL, but not the activation of Ras/ERK cascade. Taken together, we provide evidences that induction of TGF-β1 production and Smad3 phosphorylation by Ox-LDL is mediated by Ras/ERK/PLTP pathway in human alveolar epithelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism
  • Gene Expression Regulation / drug effects*
  • Genes, ras / genetics
  • Humans
  • Hypolipidemic Agents / pharmacology
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, LDL / pharmacology*
  • MAP Kinase Kinase Kinase 3 / genetics
  • MAP Kinase Kinase Kinase 3 / metabolism*
  • MAP Kinase Signaling System / drug effects
  • Mevalonic Acid / pharmacology
  • Phospholipid Transfer Proteins / genetics
  • Phospholipid Transfer Proteins / metabolism*
  • Phosphorylation
  • Pulmonary Alveoli / cytology
  • Pulmonary Alveoli / metabolism
  • RNA, Small Interfering
  • Respiratory Distress Syndrome / metabolism
  • Simvastatin / pharmacology
  • Smad3 Protein / genetics
  • Smad3 Protein / metabolism*
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism*

Substances

  • Hypolipidemic Agents
  • Lipoproteins, LDL
  • PLTP protein, human
  • Phospholipid Transfer Proteins
  • RNA, Small Interfering
  • SMAD3 protein, human
  • Smad3 Protein
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • oxidized low density lipoprotein
  • Simvastatin
  • MAP Kinase Kinase Kinase 3
  • Mevalonic Acid